RBC Europe’s Cabaletta Bio CABA Stock Holding History

RBC Europe’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-278	Closed	-$3.38K	–	704
2021 Q3	$3.38K	Hold	278	–	–	﹤0.01%	1082
2021 Q2	$2.39K	Hold	278	–	–	﹤0.01%	1107
2021 Q1	$3.09K	Hold	278	–	–	﹤0.01%	1040
2020 Q4	$3.47K	Hold	278	–	–	﹤0.01%	1010
2020 Q3	$3.01K	Hold	278	–	–	﹤0.01%	955
2020 Q2	$3.1K	Buy	+278	New	+$2.13K	﹤0.01%	915

Other funds holding CABA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RBC Europe's CABA Position: Q4 2021 in Review

RBC Europe sold out of Cabaletta Bio (CABA) in Q4 2021, closing a stake of 278 shares — an estimated $3.38K sold.

RBC Europe first reported a position in CABA in Q2 2020 and held it in 6 quarters. The position peaked at $3.47K in Q4 2020. 66 funds tracked by Wall St. Rank hold CABA as of Q4 2021.

RBC Europe reported no remaining Cabaletta Bio position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 278 Cabaletta Bio shares in Q4 2021, an estimated $3.38K.
RBC Europe first reported a position in Cabaletta Bio in Q2 2020 and held it in 6 quarters.
RBC Europe's Cabaletta Bio position peaked at $3.47K in Q4 2020.
66 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.